Open company graph database — free web & API
Login

Fuso Pharmaceutical Industries, Ltd.

扶桑薬品工業株式会社Fuso Pharmaceutical Industries,Ltd.Alias
Ticker
Listed market
TYO
Country
Japan
Employees (consolidated)
1,374
Related companies
8
§01

Basic information

BASIC
Head office
1-7-10 Doshomachi, Chuo-ku, Osaka 541-0045
Chief executive
Mikio Toda
Capital
10,758,000,000  (107 100 million)
Employees (non-consolidated)
1,340 people
Employees (consolidated)
1,374 people
Start date
1937-03-25
End date
§02

Websites

1 DOMAINS
§03

Business

9
Pharmaceutical research and developmentManufacturingSalesPharmaceutical manufacturingPharmaceutical salesPharmaceutical research and developmentCell line development servicesClinical trial supportStable supply of pharmaceuticals
§04

Related companies

8 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Fuso Kōhatsu Co., Ltd.
Group Subsidiary
Shoumei Association
Group Alliance
cpcpps
Group
cpcpps.jp
Group
Resona Bank Co., Ltd.
Bank
Sumitomo Mitsui Trust Bank, Limited
Bank
Sumitomo Mitsui Banking Corporation
Bank
Mitsubishi UFJ Bank Ltd.
Bank
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

49 EVENTS

1937 (Showa 12): Daiwa Shokai Co., Ltd. was established. Daiwa Shokai Co., Ltd. was founded in Minami Ward, Osaka City (now Higashishinsaibashi, Chuo Ward, Osaka City).Sources

The Dawn of FusoSources

On March 25, 1937, Yamato Shokai Co., Ltd. was established in Minami-ku, Osaka (now Higashishinsaibashi, Chuo-ku, Osaka) as a sales company for domestically produced glucose.Sources

Yamato Shokai Co., Ltd. established.Sources

The Imasato Plant was established in Higashimazato, Higashinari-ku, Osaka, marking the company’s entry into pharmaceutical manufacturing, including glucose injection solutions.Sources

1943 (Showa 18): The Imazato Factory was established. The factory was set up in Higashi-Imazato, Higashinari Ward, Osaka City, marking the company's entry into pharmaceutical manufacturing, including glucose injections.Sources

Imazato Factory established.Sources

Vitanone Injection and Sterile Water for Injection.Sources

1946 (Showa 21): Vitanone injections and distilled water for injection were manufactured.Sources

Vitanone injections and distilled water for injectionSources

The company’s 10th anniversary amid the postwar turmoil. Members of the time gather around then-president Kohei Toda in front of the Inari shrine at the Imasato First Plant.Sources

1947 (Showa 22): 10th anniversary celebration. The company's 10th anniversary was celebrated amid the turmoil of the postwar period. Members of the time gather around then-president Kohei Toda in front of the Inari shrine at the Imazato First Factory.Sources

10th anniversary ceremony.Sources

Although the Imasato Plant suffered fire damage when a neighboring house caught fire, operations soon began at the Imasato Second Plant, distinguished by its sawtooth roof.Sources

1948 (Showa 23): Operations began at the Imazato Second Factory. After the Imazato Factory was damaged by a fire that broke out at a neighboring house, the Imazato Second Factory—distinguished by its sawtooth roof—began operations shortly afterward.Sources

Imazato Second Factory begins operations.Sources

The company name was changed to Fuso Pharmaceutical Industries. The Imasato Second Plant office, where the newly adopted company name can be seen.Sources

1949 (Showa 24): Company name changed. The company changed its name to Fuso Pharmaceutical Industries. The Imazato Second Factory office, where the revised company name can be seen.Sources

Company name changed.Sources

Salsobabylon Injection.Sources

1951 (Showa 26): Salsobabilon injections were manufactured.Sources

Salsobabilon injectionsSources

A branch office was opened in Okayama (pictured), along with sales offices in Osaka and Tokyo.Sources

1952 (Showa 27): Expansion of sales offices began. A branch office was opened in Okayama (pictured), along with sales offices in Osaka and Tokyo.Sources

Expansion of Sales Offices BeginsSources

The head office was relocated from Higashimazato, Higashinari-ku, Osaka, to the location of the Osaka Sales Office in Doshomachi, Higashi-ku, Osaka (at the time).Sources

1953 (Showa 28): Headquarters relocated to Doshomachi. The headquarters moved from Higashi-Imazato, Higashinari Ward, Osaka City, to the location of the Osaka Sales Office in Doshomachi, Higashi Ward, Osaka City (at the time).Sources

Moved headquarters to DoshomachiSources

Neocaldramin.Sources

1954 (Showa 29): Neocaldramines were manufactured.Sources

NeocaldraminSources

The Joto Plant was built and began operations in Morinomiya, Joto-ku, Osaka, with all employees volunteering their labor. The Imasato Plant was closed. The former Osaka Army Arsenal site is visible in the upper part of the photo.Sources

1957 (Showa 32): The Joto Factory was completed. The Joto Factory was built and began operations in Morinomiya, Joto Ward, Osaka City, with all employees contributing their labor. The Imazato Factory was closed.Sources

Joto Factory completed.Sources

Dialysis solution development.Sources

1960 (Showa 35): Development of dialysis solutions began.Sources

Dialysis solution development.Sources

Expansion of production facilities.Sources

1975 (Showa 50): Production facilities were expanded.Sources

Expansion of production facilitiesSources

Listed on the First Section of the Tokyo Stock Exchange.Sources

1989 (Showa 64): Listed on the First Section of the Tokyo Stock Exchange.Sources

Listed on the First Section of the Tokyo Stock Exchange.Sources

Shift to powdered dialysis agents.Sources

2000 (Heisei 12): Switched to powder-form dialysis agents.Sources

Transition to powdered dialysis solutionSources

Transition to the Prime Market.Sources

2019 (Reiwa 1): Moved to the Prime Market.Sources

Transition to the Prime MarketSources

§07

News

2 ARTICLES

Fuso Pharmaceutical Industries Receives Asia Dialysis Drug Development Company AwardSources

Fuso Pharmaceutical Industries Ltd. was selected as the "Dialysis Drug Development Company of the Year in Asia 2026" by Pharma Tech Outlook APAC. The company's efforts and achievements in dialysis medical care were highly evaluated. Details are featured in the profile article of the magazine.

Fuso Pharmaceutical Industry Opens Official X AccountSources

Fuso Pharmaceutical Industry Co., Ltd. has established an official X account to disseminate timely information. Through this, they plan to broadly communicate their activities and employees' thoughts.

§08

Public records

GOV
National Tax Agency basic information5120001077541
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
扶桑薬品工業株式会社
Trade name (kana)
フソウヤクヒンコウギョウ
Name in English
Corporation type
301
Address
〒541-0045 大阪府大阪市中央区道修町1丁目7番10号
Postal code
5410045
Prefecture code
27
City code
128
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2018-07-13
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
4201380
METI gBizINFO5120001077541
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
5120001077541
Trade name
扶桑薬品工業株式会社
Trade name (kana)
フソウヤクヒンコウギョウ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
大阪府大阪市中央区道修町1丁目7番10号
Postal code
5410045
Prefecture
大阪府
Prefecture code
27
City or district
大阪市中央区
City code
128
Street address
道修町1丁目7番10号
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
代表取締役社長  戸 田 幹 雄
Capital
10758000000
Employees
1374
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2018-07-13
Key information
5120001077541
§09

Sources & updates

SOURCES
↑